Renal atrophy after ischemia–reperfusion injury depends on massive tubular apoptosis induced by TNFα in the later phase

Medical Molecular Morphology

Volumn 47, Issue 4, 2014, Pages 213-223

  Adachi, Takaomi ^a,b   Sugiyama, Noriyuki ^a,c   Yagita, Hideo ^d   Yokoyama, Takahiko ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Atrophy; Ischemia reperfusion injury; TNF

Indexed keywords

FAS LIGAND; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY ATROPHY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY MASS; KIDNEY TUBULE CELL; MALE; MOUSE; NEPHRON; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; ANIMAL; ISCHEMIA; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION; VASCULARIZATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ATROPHY; FAS LIGAND PROTEIN; ISCHEMIA; KIDNEY TUBULES; MALE; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84919354738     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0067-3     Document Type: Article

References (37)

1. Himmelfarb J, Ikizler TA (2007) Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int 71(10):971–976
2. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ (2006) Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17:1135–1142
3. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961–973
4. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893–899
5. Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE (2011) The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79:1361–1369
6. Finn WF (1980) Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46:440–448
7. Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814–1827
8. Linkermann A, Brasen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751–761
9. Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121:4210–4221
10. Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301–308
11. Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589–1594
12. Saikumar P, Venkatachalam MA (2003) Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23:511–521
13. Donnahoo KK, Meng X, Ao L, Ayala A, Shames BD, Cain MP, Harken AH, Meldrum DR (2001) Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxemia. Immunology 102:53–58
14. Daemen MA, van de Ven MW, Heineman E, Buurman WA (1999) Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia–reperfusion injury. Transplantation 67:792–800
15. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T (1998) Induction of apoptosis in ischemia–reperfusion model of mouse kidney: possible involvement of fas. J Am Soc Nephrol 9:620–631
16. Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J (2004) Small interfering rna targeting fas protects mice against renal ischemia–reperfusion injury. Proc Natl Acad Sci USA 101:14883–14888
17. Du C, Wang S, Diao H, Guan Q, Zhong R, Jevnikar AM (2006) Increasing resistance of tubular epithelial cells to apoptosis by shrna therapy ameliorates renal ischemia–reperfusion injury. Am J Transpl 6:2256–2267
18. Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, Xiao Z, Yagita H, Racusen L, Hamad AR, Rabb H (2011) Blocking Fas ligand on leukocytes attenuates kidney ischemia–reperfusion injury. J Am Soc Nephrol 22:732–742
19. Sugiyama N, Yokoyama T (2006) Sustained cell proliferation of renal epithelial cells in mice with inv mutation. Genes Cells 11:1213–1224
20. Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch 64:171–180
21. Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig J Tech Methods Pathol 81:1503–1515
22. Aten J, Roos A, Claessen N, Schilder-Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of cd134 ligand and tnf receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438
23. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72–82
24. Linkermann A, Himmerkus N, Rolver L, Keyser KA, Steen P, Brasen JH, Bleich M, Kunzendorf U, Krautwald S (2011) Renal tubular fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int 79:169–178
25. Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR (2005) Tnfr1- and tnfr2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. Faseb J 19:1637–1645
26. Vielhauer V, Stavrakis G, Mayadas TN (2005) Renal cell-expressed tnf receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Investig 115:1199–1209
27. Ramesh G, Reeves WB (2003) Tnfr2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol 285:F610–F618
28. Guo G, Morrissey J, McCracken R, Tolley T, Klahr S (1999) Role of tnfr1 and tnfr2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766–F772
29. Fang L, Fang J, Chen CQ (2001) Tnf receptor-associated factor-2 binding site is involved in tnfr75-dependent enhancement of tnfr55-induced cell death. Cell Res 11:217–222
30. Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) Tnf-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol 288:F406–F411
31. Zhang X, Zheng X, Sun H, Feng B, Chen G, Vladau C, Li M, Chen D, Suzuki M, Min L, Liu W, Garcia B, Zhong R, Min WP (2006) Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation 82:1728–1732
32. Hotta K, Sho M, Yamato I, Shimada K, Harada H, Akahori T, Nakamura S, Konishi N, Yagita H, Nonomura K, Nakajima Y (2011) Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. Kidney Int 79:179–188
33. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transpl 14:1158–1162
34. Gwinner W, Hinzmann K, Erdbruegger U, Scheffner I, Broecker V, Vaske B, Kreipe H, Haller H, Schwarz A, Mengel M (2008) Acute tubular injury in protocol biopsies of renal grafts: prevalence, associated factors and effect on long-term function. Am J Transpl 8:1684–1693
35. Siew ED, Peterson JF, Eden SK, Hung AM, Speroff T, Ikizler TA, Matheny ME (2012) Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol 23:305–312
36. Silva LC, Ortigosa LC, Benard G (2010) Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2(6):817–833
37. Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122–2127